Navigation Links
Pharmaxis Previews New Bronchial Challenge Test at the Annual Meeting of the American College of Allergy, Asthma and Immunology
Date:11/10/2010

EXTON, Pa., Nov. 10, 2010 /PRNewswire/ -- Pharmaxis, a global specialty pharmaceutical company focused on therapeutic products for respiratory and immune disorders, will present ARIDOL™ (mannitol inhalation powder) Bronchial Challenge Test Kit, at the 2010 Annual Meeting of the American College of Allergy, Asthma and Immunology (ACAAI), November 11-16 in Phoenix, AZ.  

Approved by the U.S. Food and Drug Administration (FDA) on October 5, 2010, ARIDOL is the first new bronchial challenge test in more than two decades.  It is used for the assessment of bronchial hyperresponsiveness in patients six years of age and older who do not have clinically apparent asthma.  The easy-to-administer, single-use test, which delivers dry powder mannitol to the patient through a hand-held inhaler, can be conducted in a variety of healthcare settings including physician offices and pulmonary function labs.  ACAAI meeting attendees can preview ARIDOL and see a demonstration of how it works at the Pharmaxis booth #s1124 and 1126.

ARIDOL is an easy-to-administer, accurate and reproducible bronchial challenge test that requires minimal preparation and administration time.  A positive response is indicated when there is a 15% reduction in lung function from baseline.  

ARIDOL has been found effective and recognized as generally safe in two Phase III global clinical trials. It is widely recognized by experts as a significant addition to the tools available to help in an overall clinical assessment of asthma.  ARIDOL should not be used as a stand-alone tool to assess asthma, but as part of a physician's overall assessment of asthma.

Other Bronchial Challenge Tests

Unlike other bronchial challenge tests, ARIDOL is a single-use test that requires less preparation time, eliminates reconstitution and use of a nebulizer to administer, with little clean-up and sterilization.  A positive ARIDOL test i
'/>"/>

SOURCE Pharmaxis
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Pharmaxis Long-Term Safety Study of Bronchitol Completes
2. Pharmaxis Establishes Named Patient Program for Bronchitol
3. Pharmaxis Concludes Special Protocol Assessment with FDA for Bronchitol Phase 3 Trial
4. ASX/NASDAQ Media Release: Pharmaxis Files First Marketing Application for Bronchitol in Australia
5. Pharmaxis Announces New Drug Application Submission for Aridol(TM)
6. Pharmaxis Announces Milestone in Phase III Trial for Cystic Fibrosis
7. Pharmaxis Announces Positive Results of Phase 3 Cystic Fibrosis Trial
8. FDA Approves Pharmaxis ARIDOL™ (Mannitol Inhalation Powder) Bronchial Challenge Test Kit for the Assessment of Bronchial Hyperresponsiveness
9. Pharmaxis Announces Positive Combined Phase 3 Cystic Fibrosis Trial Results
10. Emphasys Medical Granted Expedited Review From FDA for Zephyr(R) Endobronchial Valve
11. Pivotal Data Show Bronchial Thermoplasty Can Improve Quality of Life and Reduce Asthma Attacks and Emergency Room Visits for Adults with Severe Asthma
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2015)... Wash. , July 28, 2015 A ... of Nutraceutix,s L. reuteri probiotic enriches human ... that increase insulin secretion.  The study involved daily administration ... SD-5865) in tablets using the patented BIO- tract ... damage by stomach acid on their way to the ...
(Date:7/28/2015)... July 28, 2015  SeraCare Life Sciences, a ... announced today at the American Association of Clinical ... licensing agreement with the University of California, San ... (T21), Trisomy 18 (T18) and Trisomy 13 (T13) ... creating "patient-like" reference materials for Non-Invasive Prenatal Testing ...
(Date:7/28/2015)... The Physician-Patient Alliance for Health & Safety ... Surviving Your Hospital Stay ." "Help us ... of these patients went home from hospital," said ... referring to the patient stories presented at ... Promote Continuous Monitoring of Patients on Opioids (shown ...
Breaking Medicine Technology:Nutraceutix's L. reuteri Probiotic Clinically Proven to Modulate Gut Insulin Metabolism 2SeraCare Life Sciences Signs License Agreement with UCSF and Announces Early Access Program for Development of Aneuploidy Reference Materials 2SeraCare Life Sciences Signs License Agreement with UCSF and Announces Early Access Program for Development of Aneuploidy Reference Materials 3Surviving Your Hospital Stay: Physician-Patient Alliance for Health & Safety Launches Fundraising for Patient Safety 2
... Feb. 25 Dr. Robert B. Arnot ... The Silent Threat," the result of months of comprehensive ... hard surfaces are emerging as a key source of bacterial ... correspondent and Chief Medical Educator of www.touchsurfaces.org , also ...
... March 11 Caraco Pharmaceutical Laboratories, Ltd. (NYSE: ... 50mg and 100mg oxaliplatin injections, which are therapeutically equivalent ... Food and Drug Administration (FDA) for Sun Pharma,s Abbreviated ... in the treatment of colon and rectal cancer. Oxaliplatin ...
Cached Medicine Technology:Dr. Robert B. Arnot Releases White Paper on the Silent Threat of H1N1 and Other Infectious Diseases 2Dr. Robert B. Arnot Releases White Paper on the Silent Threat of H1N1 and Other Infectious Diseases 3Caraco Pharmaceutical Laboratories, Ltd. Markets Generic Eloxatin(R) 2Caraco Pharmaceutical Laboratories, Ltd. Markets Generic Eloxatin(R) 3
(Date:7/29/2015)... (PRWEB) , ... July 29, 2015 , ... We are privileged to announce that ... of USC as the ninth best ophthalmology hospital in the nation for 2015-2016. This marks ... American hospitals for ophthalmology. , “It is an honor to be included in the ...
(Date:7/29/2015)... ... July 29, 2015 , ... Inspired ... Foundation in March, Steven W. Meier M.D., a prominent orthopedic surgeon and regenerative ... patients with demonstrated financial need. , “We are thrilled for this opportunity to ...
(Date:7/29/2015)... ... July 29, 2015 , ... ... in a Clinical Performance Study for the Invisiport at Wheaton Franciscan Healthcare in ... catheter options, offers a less invasive, patient-friendly alternative to traditional chest ports and ...
(Date:7/29/2015)... Louis, MO (PRWEB) , ... July 29, 2015 ... ... anticipation of a decision from the Judicial Panel on Multidistrict Litigation (JPML), according ... and birth defects research at their website, the Zofran Birth Defects Lawsuit Center. ...
(Date:7/29/2015)... ... ... The Woodlands and Spring Fit Body Boot Camps have implemented an engaging ... month. The new system will track each time a client uses social media to ... the boot camps will donate 20 cents to a selected charity. , Fit Body ...
Breaking Medicine News(10 mins):Health News:21 Years & Counting: The USC Eye Institute Ranks in the Top 10 Ophthalmology Hospitals in America 2Health News:21 Years & Counting: The USC Eye Institute Ranks in the Top 10 Ophthalmology Hospitals in America 3Health News:Orthopedic Surgeon Announces New Pro Bono Prolotherapy and Regenerative Medicine Clinic for Underserved Communities in Los Angeles 2Health News:Stealth Therapeutics Inc. Enrolls First Patients in a Clinical Performance Study for the Invisiport Product Line 2Health News:Stealth Therapeutics Inc. Enrolls First Patients in a Clinical Performance Study for the Invisiport Product Line 3Health News:Zofran Lawsuit News: Zofran Lawsuits Stayed, Awaiting MDL Decision 2Health News:Zofran Lawsuit News: Zofran Lawsuits Stayed, Awaiting MDL Decision 3Health News:Zofran Lawsuit News: Zofran Lawsuits Stayed, Awaiting MDL Decision 4Health News:Transforming Texan Lives and Bodies: Woodlands and Spring Fitness Boot Camps Commit to Multiple Charity Donations 2Health News:Transforming Texan Lives and Bodies: Woodlands and Spring Fitness Boot Camps Commit to Multiple Charity Donations 3
... ... dogs and cats. For the month of May, PETCO and Blue Buffalo are partnering to raise ... with 100 percent of the donations going to the Morris Animal Foundation to fund research and ... Wilton, ...
... ... industry is expected to grow enormously over the next few years and ... This translates to greater employment opportunities for those individuals educated and trained ... the Baby Boomer generation will bring with it a strong demand for ...
... Many cancers detected by screening tests are not destined to ... as overdiagnosis. And because overdiagnosis leads to unnecessary treatment ... research strategies to quantify, recognize, and manage it, according to ... of the National Cancer Institute. H. Gilbert Welch, ...
... of a novel lensless imaging technology for use in ... taken his work a step further ― or tinier: ... world,s smallest and lightest for telemedicine applications. ... online in the journal Lab on a Chip, builds ...
... of Medicine scientists explain a potentially new early cancer ... in an article published in the Proceedings of ... how engineered gold nanoparticles tied to a cancer-specific receptor ... breast or lung cancers in humans. "When ...
... ... in Orlando , ... NJ (PRWEB) April 22, 2010 -- The American Society of Hand Therapists (ASHT) is hosting ... Royale Orlando Hotel and Convention Center in Orlando. , , ,ASHT will first hold its ...
Cached Medicine News:Health News:BLUE Buffalo Pet Food and PETCO Partner to Fight Pet Cancer During Pet Cancer Awareness Month 2Health News:BLUE Buffalo Pet Food and PETCO Partner to Fight Pet Cancer During Pet Cancer Awareness Month 3Health News:BLUE Buffalo Pet Food and PETCO Partner to Fight Pet Cancer During Pet Cancer Awareness Month 4Health News:Prospective Healthcare Workers: Fully Accredited Healthcare Degree Programs Are Now Offered Through OnlineEducation.com 2Health News:Prospective Healthcare Workers: Fully Accredited Healthcare Degree Programs Are Now Offered Through OnlineEducation.com 3Health News:Prospective Healthcare Workers: Fully Accredited Healthcare Degree Programs Are Now Offered Through OnlineEducation.com 4Health News:Prospective Healthcare Workers: Fully Accredited Healthcare Degree Programs Are Now Offered Through OnlineEducation.com 5Health News:Magnitude of overdiagnosis in cancer indicates need for strategies to address the problem 2Health News:UCLA engineer invents world's smallest, lightest telemedicine microscope 2Health News:UCLA engineer invents world's smallest, lightest telemedicine microscope 3Health News:MU researchers show potential for new cancer detection and therapy method 2Health News:Two Hand Therapy Organizations Collaborate on Jam-Packed Educational Weekend 2
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: